Manipulating PTPRD function with ectodomain antibodies
Open Access
- 1 August 2023
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 37 (15-16) , 743-759
Abstract
Protein tyrosine phosphatases (PTPs) are critical regulators of signal transduction but have yet to be exploited fully for drug development. Receptor protein tyrosine phosphatase δ (RPTPδ/PTPRD) has been shown to elicit tumor-promoting functions, including elevating SRC activity and promoting metastasis in certain cell contexts. Dimerization has been implicated in the inhibition of receptor protein tyrosine phosphatases (RPTPs). We have generated antibodies targeting PTPRD ectodomains with the goal of manipulating their dimerization status ectopically, thereby regulating intracellular signaling. We have validated antibody binding to endogenous PTPRD in a metastatic breast cancer cell line, CAL51, and demonstrated that a monoclonal antibody, RD-43, inhibited phosphatase activity and induced the degradation of PTPRD. Similar effects were observed following chemically induced dimerization of its phosphatase domain. Mechanistically, RD-43 triggered the formation of PTPRD dimers in which the phosphatase activity was impaired. Subsequently, the mAb–PTPRD dimer complex was degraded through lysosomal and proteasomal pathways, independently of secretase cleavage. Consequently, treatment with RD-43 inhibited SRC signaling and suppressed PTPRD-dependent cell invasion. Together, these findings demonstrate that manipulating RPTP function via antibodies to the extracellular segments has therapeutic potential.Keywords
Funding Information
- National Institutes of Health (CA53840, DK124907)
- CSHL Cancer Center (CA45508)
- Robertson Research Fund of CSHL
- Don Monti Memorial Research Foundation
- Irving A. Hansen Memorial Foundation
- Simons Foundation
- Robertson Research Fund of CSHL
- Cold Spring Harbor Laboratory and Northwell Health Affiliation
This publication has 66 references indexed in Scilit:
- Protein tyrosine phosphatases – from housekeeping enzymes to master regulators of signal transductionThe FEBS Journal, 2012
- Conformation-Sensing Antibodies Stabilize the Oxidized Form of PTP1B and Inhibit Its Phosphatase ActivityCell, 2011
- Should I stay or should I go? Shedding of RPTPs in cancer cells switches signals from stabilizing cell-cell adhesion to driving cell migrationCell Adhesion & Migration, 2011
- Proteoglycan-Specific Molecular Switch for RPTPσ Clustering and Neuronal ExtensionScience, 2011
- Mechanisms of cross‐talk between the ubiquitin‐proteasome and autophagy‐lysosome systemsFEBS Letters, 2009
- The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersProceedings of the National Academy of Sciences, 2009
- Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant MelanomaCancer Research, 2008
- Protein tyrosine phosphatases: from genes, to function, to diseaseNature Reviews Molecular Cell Biology, 2006
- A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesisBlood, 2006
- Furin-, ADAM 10-, and γ-Secretase-Mediated Cleavage of a Receptor Tyrosine Phosphatase and Regulation of β-Catenin's Transcriptional ActivityMolecular and Cellular Biology, 2006